Patent assignee · US · COMPANY

Fate Therapeutics, Inc.

🏢 View company profile →
47Patents
47Active
47Granted
55Portfolio score

Filing activity: Dec 19, 2011 → Jun 30, 2023

Most-cited patents

PatentTitleAreaCited byStatus
US10287606B2 Genomic engineering of pluripotent cells Emerging Cross-Sectional Technologies 22 Active
US10626372B1 Methods and compositions for inducing hematopoietic cell differentiation Chemistry; Metallurgy 15 Active
US10927346B2 Enhanced immune effector cells and use thereof Chemistry; Metallurgy 14 Active
US11072781B2 Genomic engineering of pluripotent cells Emerging Cross-Sectional Technologies 14 Active
US10858628B2 Methods and compositions for inducing hematopoietic cell differentiation Emerging Cross-Sectional Technologies 12 Active
US9452186B2 Enhanced stem cell composition Chemistry; Metallurgy 11 Active
US10023879B2 Minimal volume reprogramming of mononuclear cells Chemistry; Metallurgy 11 Active
US11365394B2 Enhanced immune effector cells and use thereof Chemistry; Metallurgy 8 Active
US10954529B2 Minimal volume reprogramming of mononuclear cells Chemistry; Metallurgy 7 Active
US10947505B2 Methods and compositions for inducing hematopoietic cell differentiation Emerging Cross-Sectional Technologies 6 Active
US9732319B2 Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs Chemistry; Metallurgy 5 Active
US10844356B2 Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs Chemistry; Metallurgy 5 Active
US11413309B2 Compositions and methods for immune cell modulation in adoptive immunotherapies Emerging Cross-Sectional Technologies 4 Active
US11096964B2 Compositions and methods for immune cell modulation in adoptive immunotherapies Emerging Cross-Sectional Technologies 4 Active
USD998174S1 Vial rack General 4 Active
US11162076B2 Methods and compositions for inducing hematopoietic cell differentiation Emerging Cross-Sectional Technologies 4 Active
US11162075B2 Methods and compositions for inducing hematopoietic cell differentiation Emerging Cross-Sectional Technologies 4 Active
US11268069B2 Reprogramming methods and cell culture platforms Chemistry; Metallurgy 3 Active
US10851412B2 Cell potency assay for therapeutic potential Chemistry; Metallurgy 3 Active
US11441126B2 Platform for the induction and maintenance of ground state pluripotency Chemistry; Metallurgy 2 Active
US11634688B2 Methods and compositions for inducing hematopoietic cell differentiation Chemistry; Metallurgy 2 Active
US11932870B2 Compositions and methods for immune cell modulation in adoptive immunotherapies Emerging Cross-Sectional Technologies 2 Active
US11352607B2 Genomic engineering of pluripotent cells Emerging Cross-Sectional Technologies 2 Active
US9403885B2 Wnt compositions and therapeutic uses of such compositions Chemistry; Metallurgy 1 Active
US9943545B2 Stem cell culture media and methods of enhancing cell survival Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.